GHO Capital and Vistria Group are joining hands to acquire Alcami, acontract development and manufacturing organization serving biotech and pharma companies, from Madison Dearborn Partners and Ampersand Capital Partners.
Why it matters: The transaction illustrates that companies perceived as high-quality, profitable and growing — buoyed by strong industry tailwinds (there are many in pharma services) — can still get financed amid the current debt drought.
